Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Primary Membranous Nephropathy: early-phase trial registry
7 of 9 indexed Primary Membranous Nephropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 7 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Primary Membranous Nephropathy: 9 US clinical trials tracked, 7 recruiting.
Primary Membranous Nephropathy is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Cerium Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition primary-membranous-nephropathy
OPEN 7 | RECR 78% | LATE 3 | EARLY 6 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)
Primary Membranous Nephropathy lists 7 open slots (78% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Primary Membranous Nephropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Primary Membranous Nephropathy is recruiting above its size-band peers.
7 of 9 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Primary Membranous Nephropathy trials is spread across many organizations.
Cerium Pharmaceuticals accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Primary Membranous Nephropathy enrolment sits around 142 participants.
Median target enrolment is 142 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.
-
Primary Membranous Nephropathy research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Biogen
NCT06962800
A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Vertex Pharmaceuticals Incorporated
NCT07204275
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Cerium Pharmaceuticals
NCT05696613
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Walden Biosciences
NCT06466135
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Nkarta
NCT06557265
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Climb Bio
NCT07096843
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Alexion Pharmaceuticals
NCT07157787
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
BeOne Medicines
NCT05707377
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
Hoffmann-La Roche
NCT04629248
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Primary Membranous Nephropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Primary Membranous Nephropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Primary Membranous Nephropathy page
9 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Primary Membranous Nephropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cerium Pharmaceuticals sponsors the most Primary Membranous Nephropathy trials on record, review their full trial history before evaluating a specific study. See Cerium Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Primary Membranous Nephropathy condition card totals 9 registered trials; most-linked intervention Tacrolimus; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.